Strategic patenting as an obstacle before the market entry of generic medicinal products
Abstract The pharmaceutical industry bears significant costs for research and development as well as the unpredictability of whether a new medicinal product shall reach the pharmaceutical market. Once a medicinal product is launched onto the market, the profits from this medicinal product should compensate the costs incurred for the medicinal products which did not reach